Sponsor Dossier
Seed Pharma
Sponsor Dossier for Seed Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ATLIPOS
- Brand: DAPAGLIFLOZIN
- Brand: LINAON
- Brand: MSN-ATORVASTATIN
- Brand: MSN-DAPAGLIFLOZIN
- Brand: MSN-LINAGLIPTIN
- Brand: MSN-NILOTINIB
- Brand: MSN-TAPENTADOL
About
Seed Pharma is an Australian Private Company with ABN 81612154373, registered in Victoria. The company is currently active.
Portfolio
Seed Pharma has 15 brands on the ARTG, of which 3 are indexable and 3 carry a Product Information document. 2 brands are PBS-listed, 0 have a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include ATLIPOS, DAPAGLIFLOZIN, LINAON, MSN-ATORVASTATIN, MSN-DAPAGLIFLOZIN, MSN-LINAGLIPTIN, MSN-NILOTINIB, MSN-TAPENTADOL, NILOTAS, NILOTEC, NILOTINIB VIATRIS, PHARMACOR.
Therapeutic focus
— Oncology: 4 brands — Pain Management: 4 brands — Endocrinology: 4 brands — Cardiology: 2 brands — Haematology: 1 brand
PBS footprint
2 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.